Nucs AI is heading to Vienna for EANM'26.

Our COO, Will Plogger, and Associate Director of Clinical Innovation & Medical Programs, Sienna Berte, will represent the team at the Annual Congress of the European Association of Nuclear Medicine.

We're looking forward to talking with nuclear medicine teams about how they select patients for radioligand therapy and track response from cycle to cycle. Our work is built around those moments: detection, prediction, and monitoring for theranostics and molecular imaging.

Book time with us through the "contact us" button above.